Paul Benson, DO
Family Medicine · Berkley, MINPI 1174554364
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $603,612 of the $778,927 with a category attached, or 77.5%. 50 manufacturers reported payments, led by Viiv Healthcare Company at 50.3% of the total. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,988 payments — averaging $391.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$392K
- Gilead$321K
- Janssen Products, LP$35K
- Janssen Scientific Affairs, LLC$15K
- Novo Nordisk$3K
- Merck$3K
- plus $10K from 44 others
Across 428 payments — averaging $7898.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1.8M
- Viiv Healthcare Company$1.3M
- Merck$146K
- GSK$84K
- Janssen Research & Development, LLC$41K
- AbbVie$16K
- plus $5K from 1 others
What the payments were for
- Consulting fees$54,4157%
- Speaking & faculty fees$603,61277%
- Travel & lodging$79,32410%
- Food & beverage$41,3165%
- Education$2600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$137,892
- Descovy$129,825
- APRETUDE$114,147
- CABENUVA$95,107
- Biktarvy$73,724
- Symtuza$48,807
- Truvada$34,030
- Yeztugo$21,311
- Juluca$3,715
- Sunlenca$2,205
- TIVICAY$885
- JATENZO$382
- FARXIGA$250
- AJOVY$233
- FREESTYLE LIBRE 3$170
- FLOWTRIEVER CATHETER, S$168
- CT THROMBECTOMY SYSTEM KIT$168
- FreeStyle Libre 2$137
- Vemlidy$125
- SPRAVATO$125
How this compares
$778,927 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 69 | $273,565 |
| DovatoDolutegravir Sodium/Lamivudine | 16 | $49,990 |
| TivicayDolutegravir Sodium | 12 | $26,689 |
| MounjaroTirzepatide | 11 | $11,689 |
| JardianceEmpagliflozin | 19 | $11,112 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 19 | $4,247 |
| Atorvastatin Calcium | 43 | $484 |
| Rosuvastatin Calcium | 36 | $473 |
| Omeprazole | 20 | $337 |
| Losartan Potassium | 21 | $269 |
| Tamsulosin Hcl | 15 | $226 |
| Levothyroxine Sodium | 23 | $161 |
| Metoprolol Succinate | 11 | $130 |
| Metformin Hcl | 25 | $101 |
| Amlodipine Besylate | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $320,908 | $273,56569 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $391,970 | $76,67928 claims |
| Lilly USA, LLCMounjaro | $336 | $11,68911 claims |
| Boehringer IngelheimJardiance | $259 | $11,11219 claims |
| GSKShingrix | $234 | $4,24719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Berkley
- Loren ChudlerSouthfield$1.3M
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
- Oren MasonGrand Rapids$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.